Regeneron Pharmaceuticals REGN Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.97B-4.9% | $3.12B+24.3% | $2.51B+24.7% | $2.02B-34.8% | $3.09B+24.3% | ||
| $5.79B+5.5% | $5.49B-7.6% | $5.94B+8.5% | $5.47B+4.1% | $5.26B-19.4% | ||
| $5.73B-0.2% | $5.74B+0.9% | $5.69B+1.4% | $5.61B+0.9% | $5.56B-10.5% | ||
| $3.1B-3.0% | $3.2B-1.6% | $3.25B+1.5% | $3.21B+0.4% | $3.19B+3.4% | ||
| $18.21B+1.0% | $18.02B+0.2% | $17.98B+6.7% | $16.86B-4.1% | $17.57B-5.8% | ||
| $40.87B+0.8% | $40.56B+1.0% | $40.17B+5.1% | $38.22B+1.8% | $37.55B-0.6% | ||
| $1.03B+9.4% | $939M+3.9% | $903.8M+24.9% | $723.9M+2.6% | $705.5M-10.6% | ||
| $636.2M+15.0% | $553M+1.4% | $545.6M+13.2% | $481.9M-22.2% | $619.3M-1.3% | ||
| $5.11B+16.9% | $4.37B-1.3% | $4.43B+20.7% | $3.67B+2.8% | $3.57B-9.6% | ||
| $1.99B0.0% | $1.99B0.0% | $1.99B0.0% | $1.99B0.0% | $1.98B0.0% | ||
| $9.45B+1.5% | $9.3B+1.0% | $9.21B+11.2% | $8.28B+1.5% | $8.16B-3.0% | ||
| $36.42B+1.8% | $35.8B+2.1% | $35.05B+4.1% | $33.68B+4.0% | $32.38B+2.2% | ||
| $31.42B+0.5% | $31.26B+1.0% | $30.96B+3.4% | $29.94B+1.9% | $29.39B+0.1% | ||
| $40.87B+0.8% | $40.56B+1.0% | $40.17B+5.1% | $38.22B+1.8% | $37.55B-0.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Regeneron Pharmaceuticals's total assets?
- Regeneron Pharmaceuticals (REGN) holds $40.9B in total assets, up 8.8% year over year.
- How much debt does Regeneron Pharmaceuticals have?
- Regeneron Pharmaceuticals carries $2.7B in total debt against $31.4B of shareholders' equity, a debt-to-equity ratio of 0.09.
- How much cash does Regeneron Pharmaceuticals have?
- Regeneron Pharmaceuticals holds $3.0B in cash and equivalents.
- Can Regeneron Pharmaceuticals cover its short-term obligations?
- Its current ratio is 3.56 — current assets exceed current liabilities.
- Where does Regeneron Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Regeneron Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
